LaparoscopicGallbladderRemovalCholecystectomy near Bronxville, NY

Biography: Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon's Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.

Biography: Dina Podolsky, MD, is an Assistant Professor of Surgery at Columbia University Irving Medical Center. She is a board-certified general surgeon who graduated with honors from Rutgers University, where she also received her medical degree, and completed a residency in general surgery at Montefiore Medical Center. Dr. Podolsky then completed fellowship training in complex abdominal wall reconstruction and robotic surgery at Columbia University Irving Medical Center, where she worked closely with one of the world's leading hernia surgeons, Dr. Novitsky. She is a member of several national organizations, including the Americas Hernia Society and the Society of American Gastrointestinal and Endoscopic Surgeons. Dr. Podolsky has received numerous awards for her training and teaching, including the Leo M. Davidoff Award for Outstanding Teaching and the Golden Apple Teaching Award. Dr. Podolsky specializes in all aspects of hernia surgery, including inguinal, ventral, and complex abdominal wall reconstruction, employing minimally invasive techniques with laparoscopic and robotic surgery. She has presented research at major professional associations and continues to be active in research, publishing both academic research and textbook chapters. Dr. Podolsky currently sees patients in midtown Manhattan and Washington Heights.

Care Philosophy: Providing excellent surgical care to patient with consideration for the emotional well being of the entire family. Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Llore is an Assistant Professor of Surgery at Columbia University and an Attending Transplant Surgeon at New York Presbyterian Hospital. Dr. Llore received her undergraduate degree from Fordham University and her medical degree from New York University School of Medicine. She completed general surgery residency at Georgetown University Hospital and abdominal transplant/hepatobiliary fellowship training at New York Presbyterian Columbia and Weill Cornell. She received additional training on the immune response after a liver transplant and xenotransplantation with Dr. Megan Sykes at Columbia Center for Translational Immunology (CCTI). She is board-certified in general surgery and received specialty training in abdominal transplant and hepatobiliary surgery. Her practice interests focus on the surgical management of children and adults with liver and bile duct disease, including benign and malignant liver tumors. She practices minimally invasive surgical techniques in liver surgery to shorten recovery times and reduce post operative discomfort. Dr. Llore is interested in surgical education and is the Associate Program Director for the ASTS certified surgical fellowship program.

Biography: Tomoaki Kato, MD, is a noted pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Dr. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons. Dr. Kato is known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT (auxiliary partial orthotopic liver transplantation) that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor. Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Dr. Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital (previously Cedars Medical Center), beginning in 2004. Dr. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals.ResourcesFor more information, visit the Center for Liver Disease and TransplantationIf you need assistance in Chinese (Mandarin & Cantonese), please call 646-317-6325 or, visit the Columbia Liver Asian Outreach Office (English | Mandarin

Biography: Dr. McManus is a board-certified, high volume Endocrine surgeon who treats thyroid, parathyroid, and adrenal disease and serves as the Surgical Director of the Thyroid Biopsy Program. Her expertise in minimally invasive interventions, including thermal ablation of thyroid nodules and robotic adrenalectomy, allows her to provide individualized, high quality care to all of her patients. Dr. McManus earned a master's degree in Clinical Research Methods and has received national and international recognition for her work including the International Association of Endocrine Surgeons (IAES) Travel Scholar Award.

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver